What is the catalog number for CXCL2 Rabbit Polyclonal Antibody?

The catalog number for CXCL2 Rabbit Polyclonal Antibody is orb334590.

What sizes are available for CXCL2 Rabbit Polyclonal Antibody?

CXCL2 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is CXCL2 Rabbit Polyclonal Antibody in stock?

CXCL2 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

CXCL2 Rabbit Polyclonal Antibody

Anti-CXCL2 Antibody. Tested in ELISA, WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

C-X-C motif chemokine 2; Growth-regulated protein beta; Gro-beta; Macrophage inflammatory protein 2-alpha; MIP2-alpha; GRO-beta (5-73) ; GRO-beta-T; Hematopoietic synergistic factor; HSF; SB-251353; CXCL2; GRO2, GROB, MIP2A, SCYB2

UniProt

P19875

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins.

Immunogen

E. coli-derived human CXCL2 recombinant protein (Position: T39-N107) . Human CXCL2 shares 66.7% and 62.3% amino acid (aa) sequence identity with mouse and rat CXCL2, respectively.

Target

C-X-C motif chemokine 2

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Immunology & Inflammation

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

ELISA, 0.1-0.5μg/ml, - Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

11 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ELISA, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.